CXCR6, a newly defined biomarker of tissue-specific stem cell asymmetric self-renewal, identifies more aggressive human melanoma cancer stem cells.
about
Common stemness regulators of embryonic and cancer stem cellsMechanical properties of growing melanocytic nevi and the progression to melanomaSenescent cells in growing tumors: population dynamics and cancer stem cellsA resource for discovering specific and universal biomarkers for distributed stem cellsThe role of chemoattractant receptors in shaping the tumor microenvironment.The emerging role of CXC chemokines and their receptors in cancer.SACK-expanded hair follicle stem cells display asymmetric nuclear Lgr5 expression with non-random sister chromatid segregation.CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms.Overshoot during phenotypic switching of cancer cell populationsExpression of stem cell markers nanog and PSCA in gastric cancer and its significance.Established and Emerging Biomarkers in Cutaneous Malignant Melanoma.Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma.Head and neck cancer stem cells.The biology of head and neck cancer stem cells.Thoughts about cancer stem cells in solid tumors.CXCR6: the role of environment in tumor progression. Challenges for therapy.MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy.Intratumoral heterogeneity as a therapy resistance mechanism: role of melanoma subpopulations.MEK inhibitor diminishes nasopharyngeal carcinoma (NPC) cell growth and NPC-induced osteoclastogenesis via modulating CCL2 and CXCL16 expressions.Blockade of the CXCR6 signaling inhibits growth and invasion of hepatocellular carcinoma cells through inhibition of the VEGF expression.Isolation of melanoma cell subpopulations using negative selection.Antibody-drug conjugates: targeting melanoma with cisplatin encapsulated in protein-cage nanoparticles based on human ferritin.Do cancer cells undergo phenotypic switching? The case for imperfect cancer stem cell markers.Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells.Human skin-derived fibroblasts used as a 'Trojan horse' for drug delivery.
P2860
Q26777882-D07DBB7A-6A88-4E9B-BC3E-06E3F251E4CDQ27342765-A3256D28-C0AC-4A52-9E2B-D213D5D9A5D3Q28478991-969B1A52-148B-4D7A-9CCE-9853DB527F6EQ33983097-2235D47E-6ACE-457A-899D-74923F69B613Q33993124-D761B6B4-3F30-4C78-98CE-23398FC69EF7Q34263645-4D966F63-5D63-491C-9978-2DB7AB930E78Q35619608-F43C64A7-DC2A-491D-A2CB-B08074D93C67Q35987292-2B931860-6F40-4F96-B24C-BC9DE55CED15Q36192449-686CD492-FEF4-41A8-9180-0172CD095EAAQ36502900-A80F327D-0DA1-44DB-A62E-5681E875C0F9Q37069223-55AB88AD-2EE5-41C8-856E-1AD40FFBC6B7Q37615918-F00EDA44-C2D9-45A1-91EB-E6815F6C94FCQ37936020-05AC10C3-D611-4B27-985C-0E3EE976D013Q37954461-EF0C3BA0-737C-428B-BFFE-47AB59BEAC6CQ38009318-E00BFDF5-61C1-45D6-B3FF-B70C9DB4058BQ38017150-EEFD8C1F-7829-4640-8F85-7BEA564BB20AQ38018308-4D0F8AC4-D706-4460-9CCF-986B1F1A739DQ38041729-CF18F608-6351-4DEA-9B34-6835B1FF7117Q38865662-5E44AD3F-14B2-455E-8A4B-FE556BD9DAD2Q38921923-26EDC190-25A6-4429-B8A8-AA6C072C7667Q39060277-33495E91-D09B-4F9F-8076-8ED3557E04C0Q39073317-FADD7FBE-E43F-4555-AF52-98631F80EF33Q42118306-6B0FE39C-4749-42B5-9D08-A3E1FA813FC4Q47227422-2DB8B13D-70E3-4DBF-A781-F73DB44CAF47Q52883927-17CC7AF3-B1B7-4C58-B4BA-63E9AD82FEF6
P2860
CXCR6, a newly defined biomarker of tissue-specific stem cell asymmetric self-renewal, identifies more aggressive human melanoma cancer stem cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
CXCR6, a newly defined biomark ...... an melanoma cancer stem cells.
@ast
CXCR6, a newly defined biomark ...... an melanoma cancer stem cells.
@en
type
label
CXCR6, a newly defined biomark ...... an melanoma cancer stem cells.
@ast
CXCR6, a newly defined biomark ...... an melanoma cancer stem cells.
@en
prefLabel
CXCR6, a newly defined biomark ...... an melanoma cancer stem cells.
@ast
CXCR6, a newly defined biomark ...... an melanoma cancer stem cells.
@en
P2093
P2860
P50
P1433
P1476
CXCR6, a newly defined biomark ...... man melanoma cancer stem cells
@en
P2093
James L Sherley
Luca Sigalotti
Maria R Nicotra
PierGiorgio Natali
Rouzbeh Taghizadeh
Yang Hoon Huh
P2860
P304
P356
10.1371/JOURNAL.PONE.0015183
P407
P577
2010-12-22T00:00:00Z